The Role of SeDeM Characterizing the Active Substance and Polyvynilpyrrolidone Eliminating Metastable Forms in an Oral Lyophilizate - A Preformulation Study.
| dc.contributor.author | Flórez Borges, Paloma | |
| dc.contributor.author | Pérez Lozano, Pilar | |
| dc.contributor.author | García Montoya, Encarna | |
| dc.contributor.author | Miñarro Carmona, Montserrat | |
| dc.contributor.author | Jo, Enric | |
| dc.contributor.author | Manich Bou, Albert | |
| dc.contributor.author | Suñé i Negre, Josep M. (Josep Maria) | |
| dc.date.accessioned | 2019-03-08T13:17:14Z | |
| dc.date.available | 2019-03-08T13:17:14Z | |
| dc.date.issued | 2018-04-24 | |
| dc.date.updated | 2019-03-08T13:17:15Z | |
| dc.description.abstract | A preformulation study of an oral lyophilisate with cetirizine dihydrochloride (CTZ) as active ingredient, mannitol and PVP K30 as bulking agents is presented. CTZ shown a humidity content of 0.150% and a spontaneous hygroscopicity of 0.200% (both determined by SeDeM diagram), demonstrating an adequate stability behavior in solid form. A design of experiments (DoE) performed with both mannitol and PVP K30, followed by a simple factorial design (32) has determined the optimum combination of excipients and CTZ, and showed that a higher proportion of PVP K30 was able to prevent metastable forms generated by mannitol. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 681312 | |
| dc.identifier.issn | 1932-6203 | |
| dc.identifier.pmid | 29689061 | |
| dc.identifier.uri | https://hdl.handle.net/2445/129964 | |
| dc.language.iso | eng | |
| dc.publisher | Public Library of Science (PLoS) | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0196049 | |
| dc.relation.ispartof | PLoS One, 2018, vol. 13, num. 4, p. e0196049 | |
| dc.relation.uri | https://doi.org/10.1371/journal.pone.0196049 | |
| dc.rights | cc-by (c) Flórez Borges, Paloma et al., 2018 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | |
| dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | |
| dc.subject.classification | Administració de medicaments | |
| dc.subject.classification | Medicació oral | |
| dc.subject.classification | Medicaments | |
| dc.subject.classification | Disseny de medicaments | |
| dc.subject.other | Administration of drugs | |
| dc.subject.other | Oral medication | |
| dc.subject.other | Drugs | |
| dc.subject.other | Drug design | |
| dc.title | The Role of SeDeM Characterizing the Active Substance and Polyvynilpyrrolidone Eliminating Metastable Forms in an Oral Lyophilizate - A Preformulation Study. | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1